Search Within

Stuart Lichtman

  1. "Breast Medicine Service"
Formats
  1. Journal Article (5)
  2. Book Section (2)
  3. Meeting Abstract (1)
  4. Review (1)
Groups
  1. Breast Medicine Service (9)
  2. Department of Medicine (9)
  3. Gynecologic Medicine Service (9)
  4. Solid Tumor Oncology Division (9)
  5. Survivorship Research (5)
  6. Biostatistics Service (1)

More Groups

People
  1. Jasmeet Singh (5)
  2. Tiffany Traina (2)
  3. Alexia Iasonos (1)
  4. Andrew Seidman (1)
  5. Beryl McCormick (1)
  6. Carol Aghajanian (1)

More People

Years
  1. 2021 (1)
  2. 2020 (1)
  3. 2019 (1)
  4. 2016 (1)
  5. 2015 (2)
  6. 2012 (2)

More Years

Publications
  1. Drugs & Aging (2)
  2. Annals of Oncology (1)
  3. ESMO Open (1)
  4. Expert Opinion on Drug Metabolism and Toxicology (1)
  5. Journal of Clinical Oncology (1)
  6. Journal of the National Comprehensive Cancer Network (1)

More Publications

Publishers
  1. Adis International Ltd (2)
  2. American Society of Clinical Oncology (1)
  3. Elsevier Inc. (1)
  4. European Society for Medical Oncology (1)
  5. Harborside Press (1)
  6. Informa Healthcare (1)

More Publishers

Results (9)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Targeted agents for HER2-positive breast cancer: Optimal use in older patients
    Review

    Singh, J. C.; Lichtman, S. M.
    Drugs & Aging (2021)

    Fulltext@MSK | Save
  • Individualizing the approach to the older woman with triple-negative breast cancer
    Book Section

    Singh, J. C.; Lichtman, S. M.
    In Tan, A. R. (Eds.) Triple-Negative Breast Cancer: A Clinician's Guide (2020)

    Fulltext@MSK | Save
  • A phase II trial of durvalumab with or without tremelimumab in patients with persistent or recurrent endometrial carcinoma and endometrial carcinosarcoma
    Meeting Abstract

    Rubinstein, M. M.; Caird, I.; Zhou, Q.; Iasonos, A.; Friedman, C. F.; Cadoo, K. A.; Konner, J. A.; O'Cearbhaill, R. E.; Tew, W. P.; Zamarin, D.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • ESMO / ASCO recommendations for a global curriculum in medical oncology edition 2016
    Journal Article

    Dittrich, C.; Kosty, M.; Jezdic, S.; Pyle, D.; Berardi, R.; Bergh, J.; El-Saghir, N.; Lotz, J. P.; Òˆsterlund, P.; Pavlidis, N.; more...
    ESMO Open (2016)

    Fulltext@MSK | Save
  • Targeted agents for HER2-positive breast cancer: Optimal use in older patients
    Journal Article

    Singh, J. C.; Lichtman, S. M.
    Drugs & Aging (2015)

    Fulltext@MSK | Save
  • Effect of age on drug metabolism in women with breast cancer
    Journal Article

    Singh, J. C.; Lichtman, S. M.
    Expert Opinion on Drug Metabolism and Toxicology (2015)

    Fulltext@MSK | Save
  • Novel and targeted therapies
    Book Section

    Zauderer, M. G.; Traina, T. A.; Lichtman, S. M.
    In Naeim, A.; Reuben, D. B.; Ganz, P. A. (Eds.) Management of Cancer in the Older Patient (2012)

    Fulltext@MSK | Save
  • Paclitaxel efficacy and toxicity in older women with metastatic breast cancer: Combined analysis of calgb 9342 and 9840
    Journal Article

    Lichtman, S. M.; Hurria, A.; Cirrincione, C. T.; Seidman, A. D.; Winer, E.; Hudis, C.; Cohen, H. J.; Muss, H. B.
    Annals of Oncology (2012)

    Fulltext@MSK | Save
  • NCCN Task Force report: Breast cancer in the older woman
    Journal Article

    Carlson, R. W.; Moench, S.; Hurria, A.; Balducci, L.; Burstein, H. J.; Goldstein, L. J.; Gradishar, W. J.; Hughes, K. S.; Jahanzeb, M.; Lichtman, S. M.; more...
    Journal of the National Comprehensive Cancer Network (2008)

    Fulltext@MSK | Save